Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Bioscience (Landmark Edition)|February 28, 2026
Neonatal Hyperoxia Induces Metabolic Reprogramming in Senescent Alveolar Macrophages, Leading to Persistent Lung InjuryFanjie Lin, Elena Pineda, Bethany McGonnigal, et al.Nutrients|November 11, 2022
Effect of Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway on Susceptibility to Non-Small-Cell Lung CancerLaura Elena Pineda Lancheros, Susana Rojo Tolosa, José María Gálvez Navas, et al.Nutrients|November 27, 2021
Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung CancerLaura Elena Pineda Lancheros, Cristina Pérez Ramírez, Almudena Sánchez Martín, et al.International Journal of Molecular Sciences|August 12, 2022
Vitamin D-Related Single Nucleotide Polymorphisms as Risk Biomarker of Cardiovascular DiseasePaula González Rojo, Cristina Pérez Ramírez, José María Gálvez Navas, et al.International Journal of Molecular Sciences|May 27, 2023
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe PsoriasisCristina Membrive-Jiménez, Cristina Pérez-Ramírez, Salvador Arias-Santiago, et al.International Journal of Molecular Sciences|August 10, 2024
SingleNucleotide Polymorphisms as Biomarkers of Mepolizumab and Benralizumab Treatment Response in Severe Eosinophilic AsthmaSusana Rojo-Tolosa, José Antonio Sánchez-Martínez, Alberto Caballero-Vázquez, et al.International Journal of Molecular Sciences|March 29, 2023
Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway and Their Relationship with High Blood Pressure RiskSusana Rojo-Tolosa, Noelia Márquez-Pete, José María Gálvez-Navas, et al.International Journal of Molecular Sciences|February 11, 2023
Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life StudySusana Rojo-Tolosa, María Victoria González-Gutiérrez, Gonzalo Jiménez-Gálvez, et al.Pharmaceutics|February 25, 2023
Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life StudySusana Rojo-Tolosa, María Victoria González-Gutiérrez, José Antonio Sánchez-Martínez, et al.International Journal of Molecular Sciences|April 28, 2023
Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic PhenotypeSusana Rojo-Tolosa, José Antonio Sánchez-Martínez, Laura Elena Pineda-Lancheros, et al.Pageof 2